London Daily

Focus on the big picture.
Wednesday, Nov 05, 2025

Government to sue Mone-linked PPE firm for £122m

Government to sue Mone-linked PPE firm for £122m

The government is suing a company that supplied it with personal protective equipment (PPE) for £122m plus costs.
PPE Medpro won contracts through the so-called VIP lane in 2020, after being recommended by Tory peer Baroness Mone.

The government is attempting to get its money back on one of the deals in the High Court, claiming the medical gowns supplied "did not comply with the specification in the contract".

PPE Medpro said it would "rigorously" defend the claim.

The company accused the government of a "cynical attempt" to recover money from suppliers who had acted in good faith and to contract specifications.

The government says along with the £122m contract, it has so far spent £6.9m on storage costs for the kit and each week it costs over £61,000 to store the gowns. It estimates the cost to dispose the gowns would be £4.7m.

According to legal documents seen by the BBC, the government claims the "the gowns did not comply with the specification in the contract" and could not be used in the NHS. It also accuses PPE Medpro of a "breach of contract and unjust enrichment".

A Department of Health and Social Care (DHSC) spokesperson said: "We can confirm that we have commenced legal proceedings in the High Court against PPE Medpro Limited for breach of contract regarding gowns delivered under a contract dated 26 June 2020.

"We do not comment on matters that are the subject of ongoing legal proceedings."

Labour's deputy leader Angela Rayner said: "After nearly a year of hiding behind a mediation process with a company linked to one of their own peers, Conservative ministers have finally been shamed into action to recover taxpayers' money after damning revelations, public outcry and Labour pressure.

"Time will now tell if the shoddy contracts they drew up are sufficiently robust to retrieve the public money they carelessly handed over."

The government has previously described the PPE Medpro medical gowns deal as an "underperforming" contract.

In a statement, the company said it was clear by the end of 2020 that the government had "vastly over-ordered" PPE and would never be able to use it all.

It said consultants had been brought in to "pick over all the contracts" on "technicalities".

"PPE Medpro will demonstrate to the courts that we supplied our gowns to the correct specification, on time and at a highly competitive price," the company said.

"The case will also show the utter incompetence of DHSC to correctly procure and specify PPE during the emergency procurement period."

The company said while it was examining the allegations made by the government it refuted all of them and said its case would "seek to dismantle" them and "make uncomfortable reading for both the government and DHSC".

The government revealed last year that Baroness Mone was the "source of referral" for PPE Medpro getting a place on the so-called VIP lane for PPE offers coming from ministers, officials or peers.

In other words, she recommended the company.

VIP lane offers were treated with greater urgency and were 10 times more likely to result in contracts than offers being made outside this route.

Baroness Mone contacted Lord Agnew, the Cabinet Office minister, about the firm and he directed the offer to the VIP lane.

She is taking a leave of absence from the House of Lords, meaning she will not sit as a Conservative peer. She says she wants to clear her name amid allegations she benefitted from the contracts.

In December 2020, lawyers for Baroness Mone said she "had no role or function in PPE Medpro, nor in the process by which contracts were awarded to PPE Medpro".

The House of Lords commissioner for standards has launched an investigation into her "alleged involvement in procuring contracts for PPE Medpro".

But the Commissioner's website says his investigation has been paused while the matter is investigated by the police or another agency as part of a criminal investigation.
Newsletter

Related Articles

0:00
0:00
Close
Massive Spoilers Emerge from MAFS UK 2025: Couple Swaps, Dating App Leaks and Reunion Bombshells
Kurdish-led Crime Network Operates UK Mini-Marts to Exploit Migrants and Sell Illicit Goods
UK Income Tax Hike Could Trigger £1 Billion Cut to Scotland’s Budget, Warns Finance Secretary
Tommy Robinson Acquitted of Terror-related Charge After Phone PIN Dispute
Boris Johnson Condemns Western Support for Hamas at Jewish Community Conference
HII Welcomes UK’s Westley Group to Strengthen AUKUS Submarine Supply Chain
Tragedy in Serbia: Coach Mladen Žižović Collapses During Match and Dies at 44
Diplo Says He Dated Katy Perry — and Justin Trudeau
Dick Cheney, Former U.S. Vice President, Dies at 84
Trump Calls Title Removal of Andrew ‘Tragic Situation’ Amid Royal Fallout
UK Bonds Rally as Chancellor Reeves Briefs Markets Ahead of November Budget
UK Report Backs Generational Smoking Ban Ahead of Tobacco & Vapes Bill Review
UK’s Domino’s Pizza Group Reports Modest Like-for-Like Sales Growth in Q3
UK Supplies Additional Storm Shadow Missiles to Ukraine as Trump Alleges Russian Underground Nuclear Tests
High-Profile Broodmare Puca Sells for Five Million Dollars at Fasig-Tipton ‘Night of the Stars’
Wilt Chamberlain’s One-of-a-Kind ‘Searcher 1’ Supercar Heads to Auction
Erling Haaland’s Remarkable Run: 13 Premier League Goals in 10 Matches and Eyes on History
UK Labour Peer Warns of Emerging ‘Constituency for Hating Jews’ in Britain
UK Home Secretary Admits Loss of Border Control, Warns Public Trust at Risk
President Trump Expresses Sympathy for UK Royal Family After Title Stripping of Prince Andrew
Former Prince Andrew to Lose His Last Military Title as King Charles Moves to End His Public Role
King Charles Relocates Andrew to Sandringham Estate and Strips Titles Amid Epstein Fallout
Two Arrested After Mass Stabbing on UK Train Leaves Ten Hospitalised
Glamour UK Says ‘Stay Mad Jo x’ After Really Big Rowling Backlash
Former Prince Prince Andrew Faces Possible U.S. Congressional Appearance Over Jeffrey Epstein Inquiry
UK Faces £20 Billion Productivity Shortfall as Brexit’s Impact Deepens
UK Chancellor Rachel Reeves Eyes New Council-Tax Bands for High-Value Homes
UK Braces for Major Storm with Snow, Heavy Rain and Winds as High as 769 Miles Wide
U.S. Secures Key Southeast Asia Agreements to Reshape Rare Earth Supply Chains
US and China Agree One-Year Trade Truce After Trump-Xi Talks
BYD Profit Falls 33 % as Chinese EV Maker Doubles Down on Overseas Markets
US Philanthropists Shift Hundreds of Millions to UK to Evade Regulatory Uncertainty in Trump Era
Israeli Energy Minister Delays $35 Billion Gas Export Agreement with Egypt
King Charles Strips Prince Andrew of Titles and Royal Residence
Trump–Putin Budapest Summit Cancelled After Moscow Memo Raises Conditions for Ukraine Talks
Amazon Shares Soar 11% as Cloud Business Hits Fastest Growth Since 2022
Credit Markets Flooded with More Than $200 Billion of AI-Linked Debt Issuance
U.S. Treasury Secretary Scott Bessent Says China Made 'a Real Mistake' by Threatening Rare-Earth Exports
Report Claims Nearly Two Billion Dollars in Foreign Charity Funds Flowed into U.S. Advocacy Groups
White House Refutes Reports That US Targeting Military Sites in Venezuela
Meta Seeks Dismissal of Strike 3’s $350 Million Copyright Lawsuit
Apple Exceeds Forecasts With $102.5 Billion Q3 Revenue Despite iPhone Miss
Israel's IDF Major General Yifat Tomer-Yerushalmi Admits to Act Amounting to Aiding Hamas During Wartime (Treason)
Shawbrook IPO Marks London’s Biggest UK Listing in Two Years
UK Government Split Over Backing Brazil’s $125 Billion Tropical Forest Fund Ahead of COP30
J.K. Rowling Condemns Glamour UK Feature of Nine Trans Women as 'Men Better at Being Women'
King Charles III Removes Prince Andrew’s Titles and Orders His Departure from Royal Lodge
UK Finance Minister Reeves Releases Email Correspondence to Clarify Rental-Licence Breach
UK and Vietnam Sign Landmark Migration Deal to Fast-Track Returns of Irregular Arrivals
UK Drug-Pricing Overhaul Essential for Life-Sciences Ambition, Says GSK Chief
×